Despite Colombia’s legalization and regulation of medical cannabis, patients still face major barriers including stigma, high costs, lack of insurance coverage, and insufficient guidance for doctors, which often forces them to seek unreliable products on the informal market, putting their health at risk. Expanding insurance coverage and improving education for healthcare providers could make safe, effective cannabis-based treatments accessible to those who need them most.
I have published a paper in The Colombian Journal of Chemical-Pharmaceutical Sciences together with Guillermo A. Castaño and Rafael Malagón, identifying key barriers to access to medical cannabis in Colombia:
- Stigma: Persistent myths and negative attitudes among the public and even healthcare professionals make it harder for patients to seek or receive treatment.
- Regulatory Gaps: Complex, evolving laws and lack of clear clinical guidelines leave both patients and doctors uncertain about how to access or prescribe cannabis-based medicines.
- Lack of Training: Many healthcare workers don’t feel confident or knowledgeable enough to prescribe medicinal cannabis.
- High Costs & Limited Coverage: With medical cannabis often excluded from insurance plans, patients face high out-of-pocket costs—or risk buying unregulated products of questionable quality.
- Systemic Barriers: Limited availability of approved products and bureaucratic hurdles further restrict access.
The takeaway: To ensure patients get the care they need, Colombia must address stigma, educate healthcare providers, streamline regulations, and expand insurance coverage for medical cannabis. This will improve treatment options and could even reduce overall healthcare costs.
@Medicannips IPS Colombia: https://lnkd.in/guCTjCMM